LOAMU
PFE icon

Lombard Odier Asset Management (USA)’s Pfizer PFE Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-52,700
Closed -$1.77M – 283
2018
Q1 		$1.77M Buy
+52,700
New +$1.81M 0.13% 148
2017
Q3 		– Sell
-40,052
Closed -$1.28M – 246
2017
Q2 		$1.28M Buy
+40,052
New +$1.26M 0.1% 175

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s PFE Position: Q3 2017 in Review

Lombard Odier Asset Management (USA) sold out of Pfizer (PFE) in Q3 2017, closing a stake of 19,499 shares — an estimated $621K sold.

Lombard Odier Asset Management (USA) first reported a position in PFE in Q3 2015 and held it in 4 quarters. The position peaked at $5.91M in Q3 2015. 2,041 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Lombard Odier Asset Management (USA) reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 19,499 Pfizer shares in Q3 2017, an estimated $621K.
  • Lombard Odier Asset Management (USA) first reported a position in Pfizer in Q3 2015 and held it in 4 quarters.
  • Lombard Odier Asset Management (USA)'s Pfizer position peaked at $5.91M in Q3 2015.
  • 2,041 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2017, filed 14 Nov 2017.